122 related articles for article (PubMed ID: 27546224)
1. Alendronate alters osteoblast activities.
Krüger TB; Herlofson BB; Landin MA; Reseland JE
Acta Odontol Scand; 2016 Oct; 74(7):550-557. PubMed ID: 27546224
[TBL] [Abstract][Full Text] [Related]
2. Alendronate promotes bone formation by inhibiting protein prenylation in osteoblasts in rat tooth replantation model.
Komatsu K; Shimada A; Shibata T; Wada S; Ideno H; Nakashima K; Amizuka N; Noda M; Nifuji A
J Endocrinol; 2013 Nov; 219(2):145-58. PubMed ID: 24096963
[TBL] [Abstract][Full Text] [Related]
3. Nitrogen Containing Bisphosphonates Impair the Release of Bone Homeostasis Mediators and Matrix Production by Human Primary Pre-Osteoblasts.
Giannasi C; Niada S; Farronato D; Lombardi G; Manfredi B; Farronato G; Brini AT
Int J Med Sci; 2019; 16(1):23-32. PubMed ID: 30662325
[TBL] [Abstract][Full Text] [Related]
4. The cytotoxic effects of three different bisphosphonates in-vitro on human gingival fibroblasts, osteoblasts and osteogenic sarcoma cells.
Açil Y; Möller B; Niehoff P; Rachko K; Gassling V; Wiltfang J; Simon MJ
J Craniomaxillofac Surg; 2012 Dec; 40(8):e229-35. PubMed ID: 22082730
[TBL] [Abstract][Full Text] [Related]
5. Serial administration of rhBMP-2 and alendronate enhances the differentiation of osteoblasts.
Kim SH; Choi HJ; Yoon DS; Son CN
Int J Rheum Dis; 2021 Oct; 24(10):1266-1272. PubMed ID: 34324274
[TBL] [Abstract][Full Text] [Related]
6. Differences in otosclerotic and normal human stapedial osteoblast properties are normalized by alendronate in vitro.
Gronowicz G; Richardson YL; Flynn J; Kveton J; Eisen M; Leonard G; Aronow M; Rodner C; Parham K
Otolaryngol Head Neck Surg; 2014 Oct; 151(4):657-66. PubMed ID: 25085325
[TBL] [Abstract][Full Text] [Related]
7. Alendronate has an anabolic effect on bone through the differentiation of mesenchymal stem cells.
Duque G; Rivas D
J Bone Miner Res; 2007 Oct; 22(10):1603-11. PubMed ID: 17605634
[TBL] [Abstract][Full Text] [Related]
8. The Effect of Alendronate Loaded Biphasic Calcium Phosphate Scaffolds on Bone Regeneration in a Rat Tibial Defect Model.
Park KW; Yun YP; Kim SE; Song HR
Int J Mol Sci; 2015 Nov; 16(11):26738-53. PubMed ID: 26561810
[TBL] [Abstract][Full Text] [Related]
9. Bisphosphonates hinder osteoblastic/osteoclastic differentiation in the maxillary sinus mucosa-derived stem cells.
Zhang J; Park J; Lee JW; Kwon YD; Kim EC
Clin Oral Investig; 2018 Jun; 22(5):1933-1943. PubMed ID: 29188452
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of inhibitors of DNA binding/differentiation gene during alendronate-induced osteoblast differentiation.
Kang AR; Oh YR; Kim HY; Park MJ; Joo BS; Choi WJ; Lee JY; Jung MH; Ji YI; Choi JS
Arch Gynecol Obstet; 2012 May; 285(5):1331-8. PubMed ID: 22116314
[TBL] [Abstract][Full Text] [Related]
11. Aminobisphosphonates cause osteoblast apoptosis and inhibit bone nodule formation in vitro.
Idris AI; Rojas J; Greig IR; Van't Hof RJ; Ralston SH
Calcif Tissue Int; 2008 Mar; 82(3):191-201. PubMed ID: 18259679
[TBL] [Abstract][Full Text] [Related]
12. Effects of alendronate on the proliferation and osteogenic differentiation of MG-63 cells.
Xiong Y; Yang HJ; Feng J; Shi ZL; Wu LD
J Int Med Res; 2009; 37(2):407-16. PubMed ID: 19383235
[TBL] [Abstract][Full Text] [Related]
13. Vascular action of bisphosphonates: In vitro effect of alendronate on the regulation of cellular events involved in vessel pathogenesis.
Cutini PH; Rauschemberger MB; Sandoval MJ; Massheimer VL
J Mol Cell Cardiol; 2016 Nov; 100():83-92. PubMed ID: 27705747
[TBL] [Abstract][Full Text] [Related]
14. Zoledronic acid suppresses mineralization through direct cytotoxicity and osteoblast differentiation inhibition.
Patntirapong S; Singhatanadgit W; Chanruangvanit C; Lavanrattanakul K; Satravaha Y
J Oral Pathol Med; 2012 Oct; 41(9):713-20. PubMed ID: 22563819
[TBL] [Abstract][Full Text] [Related]
15. Immobilization of alendronate on titanium via its different functional groups and the subsequent effects on cell functions.
Zheng D; Neoh KG; Kang ET
J Colloid Interface Sci; 2017 Feb; 487():1-11. PubMed ID: 27743540
[TBL] [Abstract][Full Text] [Related]
16. Osteoblast proliferation and maturation by bisphosphonates.
Im GI; Qureshi SA; Kenney J; Rubash HE; Shanbhag AS
Biomaterials; 2004 Aug; 25(18):4105-15. PubMed ID: 15046901
[TBL] [Abstract][Full Text] [Related]
17. Effects of alendronate on human osteoblast-like MG63 cells and matrix metalloproteinases.
Sun J; Song F; Zhang W; Sexton BE; Windsor LJ
Arch Oral Biol; 2012 Jun; 57(6):728-36. PubMed ID: 22251575
[TBL] [Abstract][Full Text] [Related]
18. The effect of alendronate soaking and ultraviolet treatment on bone-implant interface.
Kim HS; Lee JI; Yang SS; Kim BS; Kim BC; Lee J
Clin Oral Implants Res; 2017 Sep; 28(9):1164-1172. PubMed ID: 27458172
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous delivery of BMP-2 factor and anti-osteoporotic drugs using hyaluronan-assembled nanocomposite for synergistic regulation on the behaviors of osteoblasts and osteoclasts in vitro.
Zhang Y; Hu Y; Luo Z; Shen X; Mu C; Cai K
J Biomater Sci Polym Ed; 2015; 26(5):290-310. PubMed ID: 25585099
[TBL] [Abstract][Full Text] [Related]
20. Opposing effects of bisphosphonates and advanced glycation end-products on osteoblastic cells.
Gangoiti MV; Cortizo AM; Arnol V; Felice JI; McCarthy AD
Eur J Pharmacol; 2008 Dec; 600(1-3):140-7. PubMed ID: 18973752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
